ArticlePediatric blood & cancer2023

In vivo activity of the dual SYK/FLT3 inhibitor TAK-659 against pediatric acute lymphoblastic leukemia xenografts.

Keira Hughes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.